Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIT Build-up During Pollen Season
NCT01878929Phase 2Unknown
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Apr 2013
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alutard-sq in allergic rhinitis (AR), asthma and allergic conjunctivitis (AC), sponsored by University Hospitals Cleveland Medical Center. Status: unknown.
02
Drugs
alutard-sq
03
Conditions
allergic rhinitis (AR)asthmaallergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01878929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878929.